ES2183203T3 - Dispositivos de administracion de farmacos y procedimiento de preparacion. - Google Patents

Dispositivos de administracion de farmacos y procedimiento de preparacion.

Info

Publication number
ES2183203T3
ES2183203T3 ES97932630T ES97932630T ES2183203T3 ES 2183203 T3 ES2183203 T3 ES 2183203T3 ES 97932630 T ES97932630 T ES 97932630T ES 97932630 T ES97932630 T ES 97932630T ES 2183203 T3 ES2183203 T3 ES 2183203T3
Authority
ES
Spain
Prior art keywords
drug
drug administration
preparation procedure
administration devices
delivery devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97932630T
Other languages
English (en)
Inventor
David J Enscore
Patricia S Campbell
Diane E Nedberge
Richard D Frame
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2183203T3 publication Critical patent/ES2183203T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Abstract

SE EXPONE UN PROCESO PERFECCIONADO PARA FABRICAR DISPOSITIVOS QUE PERMITEN LA ADMINISTRACION TRANSDERMICA DE FARMACOS, Y LOS DISPOSITIVOS REALIZADOS A PARTIR DEL MISMO. LA INVENCION PROPORCIONA UN PROCESO DE EQUILIBRAMIENTO TERMICO PARA LA FABRICACION DE DISPOSITIVOS PARA ADMINISTRACION DE FARMACOS, QUE ELIMINA LA NECESIDAD DE CARGAR PREVIAMENTE CON UN FARMACO LA CAPA EN CONTACTO CON EL ORGANISMO. EL PROCEDIMIENTO SE APLICA PARTICULARMENTE A LA FABRICACION DE DISPOSITIVOS PARA ADMINISTRACION TRANSDERMICA DE FARMACOS, INCLUIDO UN DEPOSITO DE DROGA QUE COMPRENDE UNA CANTIDAD DE DROGA POR ENCIMA DE SU PUNTO DE SATURACION.
ES97932630T 1996-07-03 1997-07-03 Dispositivos de administracion de farmacos y procedimiento de preparacion. Expired - Lifetime ES2183203T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2112496P 1996-07-03 1996-07-03

Publications (1)

Publication Number Publication Date
ES2183203T3 true ES2183203T3 (es) 2003-03-16

Family

ID=21802466

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97932630T Expired - Lifetime ES2183203T3 (es) 1996-07-03 1997-07-03 Dispositivos de administracion de farmacos y procedimiento de preparacion.

Country Status (10)

Country Link
EP (1) EP0909167B1 (es)
AT (1) ATE226816T1 (es)
AU (1) AU721267B2 (es)
BR (1) BR9710128A (es)
CA (1) CA2259407C (es)
DE (1) DE69716737T2 (es)
ES (1) ES2183203T3 (es)
HK (1) HK1020525A1 (es)
PT (1) PT909167E (es)
WO (1) WO1998000118A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1079815B1 (de) * 1998-05-22 2004-10-20 Novosis AG Zeitgesteuert freisetzende wirkstoffhaltige transdermalsysteme
JP2002525172A (ja) * 1998-09-29 2002-08-13 ザース・インコーポレーテッド 薬剤活性化合物の改良された適用方法及び装置
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
CA2496798A1 (en) 2002-08-30 2004-03-11 Alza Corporation Embossable and writable multilaminate backing construction
US20060127463A1 (en) 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
EP2167002B1 (en) * 2007-07-10 2016-04-20 Agile Therapeutics, Inc. Dermal delivery device with in situ seal
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
MX2011011698A (es) 2009-05-04 2012-02-29 Zars Pharma Inc Metodo para tratar dolores asociados con neuroma, entrapamiento nervioso y otras condiciones.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH066534B2 (ja) * 1986-10-09 1994-01-26 積水化学工業株式会社 経皮吸収貼付剤
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
WO1992007590A1 (en) * 1990-10-29 1992-05-14 Alza Corporation Transdermal contraceptive formulations, methods and devices
PT100502A (pt) * 1991-05-20 1993-08-31 Alza Corp Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol
EP0721348B1 (en) * 1993-09-29 1999-09-01 Alza Corporation Monoglyceride/lactate ester permeation enhancer
AU695170B2 (en) * 1994-12-21 1998-08-06 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
WO1997020550A2 (en) * 1995-12-01 1997-06-12 Alza Corporation Improved method for preventing crystal formation in a dispersion of a liquid in a matrix
WO1997024148A1 (en) * 1995-12-29 1997-07-10 Cygnus, Inc. Systems and methods for the transdermal administration of androgenic agents

Also Published As

Publication number Publication date
AU721267B2 (en) 2000-06-29
DE69716737D1 (de) 2002-12-05
WO1998000118A2 (en) 1998-01-08
PT909167E (pt) 2003-03-31
HK1020525A1 (en) 2000-05-12
CA2259407A1 (en) 1998-01-08
AU3603597A (en) 1998-01-21
ATE226816T1 (de) 2002-11-15
CA2259407C (en) 2006-04-04
EP0909167A2 (en) 1999-04-21
EP0909167B1 (en) 2002-10-30
DE69716737T2 (de) 2003-03-20
WO1998000118A3 (en) 1998-03-05
BR9710128A (pt) 1999-08-10

Similar Documents

Publication Publication Date Title
DE50006156D1 (de) Vorrichtung und verwendung zur steigerung der transdermalen permeation von arzneistoffen
DE59006461D1 (de) Therapeutisches System zur verzögerten und gesteuerten transdermalen oder transmucosalen Verabreichung von Wirkstoffen (II).
PT1151004E (pt) Processo para a preparacao de il-1ra uma proteina terapeuticamente activa a partir de fluidos corporais
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
HK1083009A1 (en) Topical drug delivery using phosphatidylcholine
DE60219336D1 (de) Vorrichtung zur iontophoretischen verabreichung von medikamenten durch das augenlid
ES2154832T3 (es) Sistema transcutaneo supersaturado para distribucion de medicamentos, y procedimientos de fabricacion asociados.
HUP0203623A2 (hu) Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
DE59811840D1 (de) Zusammensetzung zur therapie von diabetes mellitus und fettsucht
EE05620B1 (et) Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid
ES2119411T5 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
ES2183203T3 (es) Dispositivos de administracion de farmacos y procedimiento de preparacion.
DE60115433D1 (de) Verfahren zur behandlung von chronischen geschwüren
EA199800866A1 (ru) Способ снятия боли
DK188680A (da) Fremgangsmaade til fremstilling af 6-substituerede 11-alkylenmorphantridiner
DE69700983D1 (de) Ligandgerichtete enzyme-prodrug therapie
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
ATE386510T1 (de) Trägermatrix mit wirkstoffbeladenen partikeln zur anwendung auf der haut oder schleimhaut
WO2002058532A3 (en) Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
DE3853079D1 (de) Liposome hoher stabilität und verfahren zur herstellung und verwendung.
BR0211323A (pt) Combinação de ingredientes ativos, uso de uma combinação de ingredientes ativos e método de terapia farmacológica de dependência de nicotina
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
ES2126308T3 (es) Sistema terapeutico percutaneo a base de estradiol con aditivos hidrofilos.
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
WO1999013894A3 (en) Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c